Lutz Stoeber

Lutz Stoeber currently serves as a Board Observer for Allay Therapeutics and Laxxon Medical, and has a long-standing role as the Head of Venture Capital & Investments North America at Evonik Venture Capital since September 2012, focusing on venture capital investments in Advanced Materials, Drug Delivery, Advanced Nutrition, and Personal Care. Additional positions include serving as Investment Director, Investment Manager - North America at Element, and various advisory roles with organizations such as Union Labs Ventures, Tech Council Ventures, and Pangaea Ventures. Lutz Stoeber holds a post-doctoral degree from Imperial College London and has educational experience from New York University and Schule Schloss Salem. Previous roles include Board Observer at Modern Meadow and Director at S&Y ACHIEVEMENT LLC, along with serving as a Senior Analyst and Investment Professional at PARDUS CAPITAL MANAGEMENT L.P.